ClinicalTrials.govpublic full text
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
castration-sensitive prostate carcinoma, metastatic prostate adenocarcinoma, stage ivb prostate cancer ajcc v8, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 825650
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.